ELOVL5 and metabolic dysfunction-associated steatohepatitis: ELOVL5 mRNA expression was slightly but significantly increased in NASH compared to NAFL2 group (Supplemental Fig. S5a) whereas ELOVL6 mRNA liver expression was significantly decreased in NASH patients (Supplemental Fig. S5b), consistent with low enzyme activity observed in NASH.